Lipid Metabolism, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | yes | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 14 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Related structures:
AlphaFold database: A4I4Z0
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 19 |
GO:0008289 | lipid binding | 2 | 19 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.441 |
CLV_NRD_NRD_1 | 360 | 362 | PF00675 | 0.474 |
CLV_PCSK_KEX2_1 | 360 | 362 | PF00082 | 0.415 |
CLV_PCSK_SKI1_1 | 15 | 19 | PF00082 | 0.376 |
CLV_PCSK_SKI1_1 | 162 | 166 | PF00082 | 0.291 |
CLV_PCSK_SKI1_1 | 207 | 211 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 334 | 338 | PF00082 | 0.467 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.365 |
DEG_APCC_DBOX_1 | 14 | 22 | PF00400 | 0.407 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.619 |
DEG_SIAH_1 | 302 | 310 | PF03145 | 0.469 |
DOC_CKS1_1 | 236 | 241 | PF01111 | 0.321 |
DOC_MAPK_gen_1 | 12 | 21 | PF00069 | 0.445 |
DOC_MAPK_gen_1 | 25 | 32 | PF00069 | 0.328 |
DOC_MAPK_gen_1 | 360 | 366 | PF00069 | 0.389 |
DOC_PP4_FxxP_1 | 117 | 120 | PF00568 | 0.278 |
DOC_USP7_MATH_1 | 189 | 193 | PF00917 | 0.246 |
DOC_USP7_MATH_1 | 268 | 272 | PF00917 | 0.672 |
DOC_USP7_MATH_1 | 31 | 35 | PF00917 | 0.294 |
DOC_USP7_UBL2_3 | 48 | 52 | PF12436 | 0.246 |
DOC_WW_Pin1_4 | 235 | 240 | PF00397 | 0.395 |
DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.412 |
LIG_14-3-3_CanoR_1 | 311 | 318 | PF00244 | 0.642 |
LIG_14-3-3_CanoR_1 | 360 | 365 | PF00244 | 0.465 |
LIG_14-3-3_CanoR_1 | 88 | 92 | PF00244 | 0.348 |
LIG_Actin_WH2_2 | 325 | 340 | PF00022 | 0.535 |
LIG_EH1_1 | 309 | 317 | PF00400 | 0.478 |
LIG_eIF4E_1 | 310 | 316 | PF01652 | 0.613 |
LIG_FHA_1 | 177 | 183 | PF00498 | 0.382 |
LIG_FHA_1 | 311 | 317 | PF00498 | 0.534 |
LIG_FHA_1 | 91 | 97 | PF00498 | 0.354 |
LIG_FHA_2 | 134 | 140 | PF00498 | 0.255 |
LIG_FHA_2 | 342 | 348 | PF00498 | 0.458 |
LIG_FHA_2 | 360 | 366 | PF00498 | 0.516 |
LIG_HCF-1_HBM_1 | 231 | 234 | PF13415 | 0.377 |
LIG_LIR_Apic_2 | 166 | 172 | PF02991 | 0.351 |
LIG_LIR_Apic_2 | 244 | 250 | PF02991 | 0.366 |
LIG_LIR_Gen_1 | 125 | 133 | PF02991 | 0.281 |
LIG_LIR_Gen_1 | 139 | 148 | PF02991 | 0.305 |
LIG_LIR_Gen_1 | 14 | 24 | PF02991 | 0.442 |
LIG_LIR_Gen_1 | 97 | 104 | PF02991 | 0.356 |
LIG_LIR_Nem_3 | 109 | 115 | PF02991 | 0.247 |
LIG_LIR_Nem_3 | 131 | 135 | PF02991 | 0.292 |
LIG_LIR_Nem_3 | 139 | 143 | PF02991 | 0.309 |
LIG_LIR_Nem_3 | 217 | 223 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 97 | 102 | PF02991 | 0.373 |
LIG_MYND_1 | 246 | 250 | PF01753 | 0.498 |
LIG_PDZ_Class_2 | 361 | 366 | PF00595 | 0.615 |
LIG_Pex14_1 | 243 | 247 | PF04695 | 0.384 |
LIG_Pex14_1 | 38 | 42 | PF04695 | 0.263 |
LIG_PTB_Apo_2 | 120 | 127 | PF02174 | 0.290 |
LIG_PTB_Apo_2 | 134 | 141 | PF02174 | 0.295 |
LIG_PTB_Phospho_1 | 134 | 140 | PF10480 | 0.410 |
LIG_SH2_CRK | 321 | 325 | PF00017 | 0.445 |
LIG_SH2_CRK | 79 | 83 | PF00017 | 0.291 |
LIG_SH2_CRK | 99 | 103 | PF00017 | 0.150 |
LIG_SH2_NCK_1 | 99 | 103 | PF00017 | 0.276 |
LIG_SH2_PTP2 | 169 | 172 | PF00017 | 0.351 |
LIG_SH2_SRC | 247 | 250 | PF00017 | 0.505 |
LIG_SH2_STAP1 | 113 | 117 | PF00017 | 0.278 |
LIG_SH2_STAP1 | 216 | 220 | PF00017 | 0.467 |
LIG_SH2_STAP1 | 42 | 46 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 169 | 172 | PF00017 | 0.270 |
LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 223 | 226 | PF00017 | 0.433 |
LIG_SH2_STAT5 | 247 | 250 | PF00017 | 0.508 |
LIG_SH2_STAT5 | 348 | 351 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.467 |
LIG_SH3_2 | 150 | 155 | PF14604 | 0.356 |
LIG_SH3_2 | 306 | 311 | PF14604 | 0.614 |
LIG_SH3_3 | 112 | 118 | PF00018 | 0.412 |
LIG_SH3_3 | 147 | 153 | PF00018 | 0.363 |
LIG_SH3_3 | 300 | 306 | PF00018 | 0.569 |
LIG_TRAF2_1 | 282 | 285 | PF00917 | 0.562 |
LIG_TYR_ITIM | 110 | 115 | PF00017 | 0.390 |
LIG_TYR_ITIM | 77 | 82 | PF00017 | 0.356 |
LIG_UBA3_1 | 18 | 26 | PF00899 | 0.321 |
MOD_CDK_SPK_2 | 235 | 240 | PF00069 | 0.347 |
MOD_CK1_1 | 163 | 169 | PF00069 | 0.302 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.344 |
MOD_CK2_1 | 128 | 134 | PF00069 | 0.263 |
MOD_CK2_1 | 268 | 274 | PF00069 | 0.606 |
MOD_CK2_1 | 279 | 285 | PF00069 | 0.762 |
MOD_CK2_1 | 341 | 347 | PF00069 | 0.500 |
MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.360 |
MOD_GlcNHglycan | 270 | 273 | PF01048 | 0.691 |
MOD_GlcNHglycan | 280 | 284 | PF01048 | 0.757 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.295 |
MOD_GSK3_1 | 189 | 196 | PF00069 | 0.298 |
MOD_GSK3_1 | 254 | 261 | PF00069 | 0.578 |
MOD_GSK3_1 | 310 | 317 | PF00069 | 0.568 |
MOD_GSK3_1 | 328 | 335 | PF00069 | 0.303 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.312 |
MOD_N-GLC_1 | 143 | 148 | PF02516 | 0.291 |
MOD_NEK2_1 | 133 | 138 | PF00069 | 0.262 |
MOD_NEK2_1 | 200 | 205 | PF00069 | 0.320 |
MOD_NEK2_1 | 290 | 295 | PF00069 | 0.626 |
MOD_NEK2_1 | 297 | 302 | PF00069 | 0.564 |
MOD_PIKK_1 | 176 | 182 | PF00454 | 0.342 |
MOD_PK_1 | 160 | 166 | PF00069 | 0.263 |
MOD_PKA_1 | 360 | 366 | PF00069 | 0.389 |
MOD_PKA_2 | 176 | 182 | PF00069 | 0.374 |
MOD_PKA_2 | 310 | 316 | PF00069 | 0.661 |
MOD_PKA_2 | 359 | 365 | PF00069 | 0.454 |
MOD_PKA_2 | 64 | 70 | PF00069 | 0.391 |
MOD_PKA_2 | 87 | 93 | PF00069 | 0.329 |
MOD_Plk_1 | 332 | 338 | PF00069 | 0.449 |
MOD_Plk_4 | 193 | 199 | PF00069 | 0.332 |
MOD_Plk_4 | 42 | 48 | PF00069 | 0.337 |
MOD_ProDKin_1 | 235 | 241 | PF00069 | 0.387 |
MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.411 |
MOD_SUMO_for_1 | 47 | 50 | PF00179 | 0.415 |
MOD_SUMO_rev_2 | 280 | 288 | PF00179 | 0.521 |
MOD_SUMO_rev_2 | 4 | 14 | PF00179 | 0.607 |
MOD_SUMO_rev_2 | 44 | 54 | PF00179 | 0.415 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.265 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.405 |
TRG_ENDOCYTIC_2 | 16 | 19 | PF00928 | 0.363 |
TRG_ENDOCYTIC_2 | 321 | 324 | PF00928 | 0.434 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.301 |
TRG_ENDOCYTIC_2 | 99 | 102 | PF00928 | 0.150 |
TRG_ER_diArg_1 | 159 | 162 | PF00400 | 0.296 |
TRG_ER_diArg_1 | 359 | 361 | PF00400 | 0.455 |
TRG_Pf-PMV_PEXEL_1 | 207 | 211 | PF00026 | 0.360 |
TRG_Pf-PMV_PEXEL_1 | 322 | 326 | PF00026 | 0.400 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6J9 | Leptomonas seymouri | 74% | 99% |
A0A0S4KH88 | Bodo saltans | 48% | 93% |
A0A1X0P910 | Trypanosomatidae | 51% | 97% |
A0A3Q8IBA5 | Leishmania donovani | 34% | 100% |
A0A3Q8IJ21 | Leishmania donovani | 100% | 100% |
A0A3R7KCX0 | Trypanosoma rangeli | 48% | 100% |
A4H6L4 | Leishmania braziliensis | 35% | 100% |
A4HHT0 | Leishmania braziliensis | 82% | 100% |
A4HUZ7 | Leishmania infantum | 34% | 89% |
C9ZKK9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 99% |
D0A7F2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9AED5 | Leishmania major | 95% | 100% |
E9ALF1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
E9ANN2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 100% |
Q4QGZ1 | Leishmania major | 36% | 100% |
Q9Y365 | Homo sapiens | 30% | 100% |
V5BC62 | Trypanosoma cruzi | 50% | 100% |
V5DT41 | Trypanosoma cruzi | 35% | 100% |